Pune: Avinash, a resident of Gokhalenagar, grappled with excruciating knee arthritis for the last five years, rendering him crippled and unable to per.

Infigratinib phosphate is under clinical development by QED Therapeutics and currently in Phase III for Achondroplasia. According to GlobalData, Phase III drugs for Achondroplasia does not have ...

Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "Achondroplasia - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Market Overview A ...

The availability of Vosoritide, a medication used for treatment of achondroplasia among children patients, will be widened following an initiative by the Georgian Government, the Ministry of Health ...

A groundbreaking drug that helps regulate bone development has boosted growth rates in children with achondroplasia - the most common type of dwarfism - in a global trial led by Melbourne's ...